The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Insurance coverage litigation for Formosa Plastics Corporation for explosion and fire loss
The firm served as lead counsel for Formosa Plastics Corporation in litigation regarding coverage for property damage and other losses suffered at more
Employee benefits for a national beverage manufacturer regarding acquisition of two publicly trading companies
Counseled a national beverage manufacturer in the employee benefits matters regarding its acquisition of two publicly traded corporation in an more
$375 million syndicated multicurrency revolving credit facility provided to a publicly-held contract staffing firm
Represented a lead agent and lead arranger in connection with $375 million syndicated multicurrency revolving credit facility provided to a more
Real estate transactional representation for national wind energy developer and lender
Represented national wind energy developer and lender in preparation and review of real estate transactional documents for wind farm projects. more